Fingers crossed shlok...i think a bigger play would be other disease funded companies fund research into their areas, which would increase the value substantially. But, time will tell.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $23.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $11.46K | 2.327M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 89724945 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27630177 | 21 |
View Market Depth
| Last trade - 15.30pm 17/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
